These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36266235)

  • 1. Association between interleukin-6 and lower urinary tract symptoms of benign prostatic hyperplasia.
    Zhang Q; Jiang K; Huo RC; Zhang JQ; Yang ZG
    Rev Int Androl; 2023; 21(2):100334. PubMed ID: 36266235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Inflammation and Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia.
    Zhang Q; Pang S; Zhang Y; Jiang K; Guo X
    Urol J; 2020 Mar; 17(5):505-511. PubMed ID: 32207139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.
    Inamura S; Ito H; Shinagawa T; Tsutsumiuchi M; Taga M; Kobayashi M; Yokoyama O
    Prostate; 2018 Jul; 78(10):743-752. PubMed ID: 29608020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study.
    Pozzi E; Boeri L; Capogrosso P; Cazzaniga W; Candela L; Fallara G; Schifano N; Costa A; Cignoli D; Tutolo M; Matloob R; Abbate C; Montorsi F; Salonia A
    Eur Urol Focus; 2022 Mar; 8(2):555-562. PubMed ID: 33757736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of glutathione S-transferase P1 gene polymorphism and metabolic syndrome in lower urinary tract symptoms attributed to benign prostatic hyperplasia.
    Zhang W; Li Z; Liu M; Mu Y; He J; Chen P; Liu D; Chen K; Che B; Xu S; Zhang H; Tang K
    World J Urol; 2021 Dec; 39(12):4413-4419. PubMed ID: 34228163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The independent association of non-alcoholic fatty liver disease with lower urinary tract symptoms/benign prostatic hyperplasia and erectile function scores.
    Eren H; Horsanali MO
    BJU Int; 2019 Aug; 124(2):329-335. PubMed ID: 30900792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of treatment with Pygeum africanum in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a cross-sectional study in the real-world clinical practice in Spain (The PROFIT Study)].
    Cambronero J; Osca-García JM; Merino-Salas S; Miguel JM; Borralleras C; López-Alcina E
    Arch Esp Urol; 2022 Apr; 75(3):219-227. PubMed ID: 35435166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between histological prostatitis and benign prostatic hyperplasia: a single-center retrospective study.
    Li J; Li Y; Cao D; Huang Y; Peng L; Meng C; Wei Q
    Aging Male; 2022 Dec; 25(1):88-93. PubMed ID: 35289705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voiding and Storage Domain-Specific Symptom Score Outcomes After Prostate Artery Embolization for Lower Urinary Tract Symptoms and Urinary Retention.
    Powell T; Staib L; Liu B; Bhatia S; Chai T; Ayyagari R
    Urology; 2021 Oct; 156():216-224. PubMed ID: 33961894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome.
    Ozer K; Horsanali MO; Gorgel SN; Horsanali BO; Ozbek E
    Urol Int; 2017; 98(4):466-471. PubMed ID: 27464069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of distally located periurethral calcification in patients with lower urinary tract symptoms of benign prostate hyperplasia.
    Yu SH; Lim DG; Kim SO
    Asian J Androl; 2023; 25(3):361-365. PubMed ID: 35946225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
    Lee JH; Kim Y; Park YW; Lee DG
    J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Viktrup L; Hayes RP; Wang P; Shen W
    BMC Urol; 2012 Nov; 12():30. PubMed ID: 23134716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The visual prostate symptom score is a simple tool to identify and follow up in general practice patients with lower urinary tract symptoms associated with benign prostatic hyperplasia (a study with 1359 patients).
    Descazeaud A; Coloby P; Taille A; Karsenty G; Kouri G; Rossi D; Carrois F; Zerbib M
    Presse Med; 2018; 47(7-8 Pt 1):e91-e98. PubMed ID: 30075950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon
    Vela-Navarrete R; Alcaraz A; Rodríguez-Antolín A; Miñana López B; Fernández-Gómez JM; Angulo JC; Castro Díaz D; Romero-Otero J; Brenes FJ; Carballido J; Molero García JM; Fernández-Pro Ledesma A; Cózar Olmos JM; Manasanch Dalmau J; Subirana Cachinero I; Herdman M; Ficarra V
    BJU Int; 2018 Dec; 122(6):1049-1065. PubMed ID: 29694707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Holmium Laser Enucleation of Prostate equally effective in management of benign prostatic hyperplasia patients with either voiding or storage lower urinary tract symptoms? A comparative study.
    Mostafa MM; Patil N; Khalil M; Elgammal MA; Mahdy A
    Arch Ital Urol Androl; 2022 Jun; 94(2):174-179. PubMed ID: 35775342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
    Inamura S; Shinagawa T; Hoshino H; Sakai Y; Imamura Y; Yokoyama O; Kobayashi M
    Prostate; 2017 May; 77(7):794-802. PubMed ID: 28181681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.
    Jhang JF; Liao CH; Kuo HC
    Int J Clin Pract; 2014 Jun; 68(6):743-8. PubMed ID: 24471413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.